Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Reducing the Burden of MS Treatment
Multiple Sclerosis Physician Resources
Highlights from the MAGNIMS Consensus Guidelines
Immunologic Effects on Metabolic Syndrome and MS
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Emerging MRI Techniques in MS Patients
Current Landscape of MS Diagnosis/Prognosis
Current and Future MS Treatment Options
The Value of Biomarkers in MS Patients
Determining an MS Patient's Long-Term Prognosis
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.
